UK drugmaker Vernalis has signed a drug discovery deal with Daiichi Sankyo Co that aims to find new targets for potential cancer therapies. More: Vernalis, Daiichi Sankyo work together on new cancer targets Source: News
read moreGlaxoSmithKline’s biologic Nucala has become the first therapy specifically approved in the US to treat a rare disease called eosinophilic granulomatosis with polyangiitis (EPGA). More: FDA OK’s GSK’s asthma biologic for rare autoimmune disease Source: News
read moreAlder Hey Children’s Hospital launches its Alder Play iPhone and Android app. More: UK hospital combines gaming and AR for patient care app Source: News
read moreJohnson & Johnson group Janssen has unveiled new data showing a 50 percent cut in the risk of disease progression or death in patients with newly diagnosed multiple myeloma given Darzalex on top of standard treatment. More: J&J’s Darzalex shows
read more© 1994 - 2026 B.M. Pharmaceuticals